Latest News

Search News
Categories
Archives
CRUK Barts Centre key partner in new £14m CRUK City of London Centre

17th September 2018

We are delighted to announce that researchers from the Barts Cancer Research UK Barts Centre will play a leading role in the new Cancer Biotherapeutics Hub launched by CRUK – The ‘CRUK City of London Centre’. The new centre will bring together world-leading cancer researchers from across London – CRUK Barts Centre, UCL, KCL and the Francis Crick Institute.

Read more

Study links widely-used drug azathioprine to skin cancers

14th September 2018

A drug used to treat inflammatory bowel disease and arthritis, and prevent organ rejection in transplant patients, has been identified as an important contributor to skin cancer development in a study by researchers from Queen Mary University of London, including our Barts Cancer Research UK Centre (BCC) Bioinformatics team, the University of Dundee and the Wellcome Sanger Institute.

Read more

VOICE 2018: From bedside to bench

12th September 2018

BCI held the 2018 VOICE (Vision On Information, Confidence & Engagement) course- a study week that aims to take patient advocates from bedside to bench by providing an introduction to basic cancer biology, research terminology and study design.

Read more

‘Chromosomal Catastrophes’ in Colorectal Cancer

5th September 2018

Understanding how cancers develop and change over time is a big challenge. For obvious reasons, scientists can’t simply sit and watch a cancer growing in a person. Members of the Evolution and Cancer Laboratory at the BCI, including lead author Dr William Cross, were part of a collaborative team that set out to identify when particular genetic changes arise during bowel cancer development.

Read more

SNPnexus: Assessing the impact of genetic variation

30th August 2018

A team of researchers from BCI’s Centre for Molecular Oncology, led by Prof Claude Chelala, have made new developments to SNPnexus- a computational tool that allows for the assessment of the functional effect of sequence variants within the genome.

Read more

Researchers identify new mechanism implicated in lung cancer progression

7th August 2018

A new study performed by researchers from BCI led by Dr Tyson Sharp, Lead of the Centre for Molecular Oncology, has identified a novel mechanism implicated in the development of lung adenocarcinoma (the most common type of non-small cell lung cancer), mediated by the loss of a gene called LIMD1.

Read more

Search News
Categories
Archives